Joshua Sharfstein

Join public health expert Josh Sharfstein—former health commissioner of Baltimore and FDA deputy commissioner—as he dives into the chaos at the CDC. They discuss how RFK Jr.'s actions may undermine public health initiatives and lead to the return of preventable diseases. The hosts analyze the implications of recent legal troubles for Trump and explore the dynamics of Congress as they face potential budget battles. With insights into public trust in health systems and the political landscape, this conversation is both timely and crucial.

This week, public health expert Josh Sharfstein shares insights from his experience as a former health commissioner and FDA official. He discusses the troubling implications of recent CDC changes, including risks to public health and vaccine accessibility. The conversation also covers the political ramifications of the Trump administration's legal challenges as they near the Supreme Court and the complicated landscape of a potential government shutdown. The team weighs in on how these issues could reshape public trust and health initiatives moving forward.

Joshua Sharfstein, a seasoned public health leader and director of the Bloomberg American Health Initiative, shares insights on pressing health issues. He discusses the ongoing opioid crisis, highlighting the risks of fentanyl and the need for accessible treatment options. Sharfstein also reflects on the lessons learned from COVID-19 vaccine distribution and the importance of building trust in health messaging. Additionally, he addresses the preparedness for potential bird flu outbreaks and advocates for clear policy standards in AI-assisted medical diagnosis.